Skip to main content

Table 2 Annual net economic benefit in Canada: Nurse time and compensation per 37 patients switched from hospital IVIg to home SCIg to recoup 1 nurse FTE

From: Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada

 

Year 1

Subsequent years

Home-based SCIg therapy

  

  Nurse hours: training

222

0

  Nurse hours: monitoring

222

222

  Nurse compensation, C$

25,565

12,783

Hospital-based IVIg therapy

  

  Nurse hours: IV administration and monitoring

2,116.4

2,116.4

  Nurse compensation, C$

121,862

121,862

Net economic benefit (IVIg – SCIg)

  

  Savings: nurse hours

1,672.4

1,894.4

  Savings: nurse compensation, C$

96,297

109,080